Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage.

Tai CJ, Su TC, Jiang MC, Chen HC, Shen SC, Lee WR, Liao CF, Chen YC, Lin SH, Li LT, Shen KH, Yeh CM, Yeh KT, Lee CH, Shih HY, Chang CC.

J Transl Med. 2013 Jan 31;11:29. doi: 10.1186/1479-5876-11-29.

2.

CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression.

Jiang MC, Yeh CM, Tai CJ, Chen HC, Lin SH, Su TC, Shen SC, Lee WR, Liao CF, Li LT, Lee CH, Chen YC, Yeh KT, Chang CC.

Am J Surg. 2013 Sep;206(3):418-27. doi: 10.1016/j.amjsurg.2012.11.021. Epub 2013 Jun 24.

PMID:
23806821
3.

Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.

Alnabulsi A, Agouni A, Mitra S, Garcia-Murillas I, Carpenter B, Bird S, Murray GI.

J Pathol. 2012 Dec;228(4):471-81. doi: 10.1002/path.4031. Epub 2012 Aug 20.

PMID:
22450763
4.

The prognostic significance of nuclear CSE1L in urinary bladder urothelial carcinomas.

Chang CC, Tai CJ, Su TC, Shen KH, Lin SH, Yeh CM, Yeh KT, Lin YM, Jiang MC.

Ann Diagn Pathol. 2012 Oct;16(5):362-8. doi: 10.1016/j.anndiagpath.2012.02.005. Epub 2012 Apr 2.

PMID:
22476051
5.

Differential distributions of CSE1L/CAS and E-cadherin in the polarized and non-polarized epithelial glands of neoplastic colorectal epithelium.

Uen WC, Tai CJ, Shen SC, Lee WR, Tsao TY, Deng WP, Chiou HY, Hsu CH, Hsieh CI, Liao CF, Jiang MC.

J Mol Histol. 2010 Oct;41(4-5):259-66. doi: 10.1007/s10735-010-9286-2. Epub 2010 Aug 24.

PMID:
20734115
6.

Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon.

Tsao TY, Tsai CS, Tung JN, Chen SL, Yue CH, Liao CF, Wang CC, Jiang MC.

Mol Cell Biochem. 2009 Jul;327(1-2):163-70. doi: 10.1007/s11010-009-0054-0. Epub 2009 Feb 18.

PMID:
19224336
7.

The relationship between CSE1L expression and axillary lymph node metastasis in breast cancer.

Yuksel UM, Dilek G, Dogan L, Gulcelik MA, Berberoglu U.

Tumori. 2015 Mar-Apr;101(2):194-8. doi: 10.5301/tj.5000239. Epub 2015 Mar 16.

PMID:
25791533
8.

CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells.

Liao CF, Luo SF, Li LT, Lin CY, Chen YC, Jiang MC.

J Exp Clin Cancer Res. 2008 Jul 3;27:15. doi: 10.1186/1756-9966-27-15.

9.

CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.

Sillars-Hardebol AH, Carvalho B, Beliën JA, de Wit M, Delis-van Diemen PM, Tijssen M, van de Wiel MA, Pontén F, Meijer GA, Fijneman RJ.

Cell Oncol (Dordr). 2012 Aug;35(4):293-300. doi: 10.1007/s13402-012-0088-2. Epub 2012 Jun 19.

PMID:
22711543
10.

Serum cellular apoptosis susceptibility protein is a potential prognostic marker for metastatic colorectal cancer.

Stella Tsai CS, Chen HC, Tung JN, Tsou SS, Tsao TY, Liao CF, Chen YC, Yeh CY, Yeh KT, Jiang MC.

Am J Pathol. 2010 Apr;176(4):1619-28. doi: 10.2353/ajpath.2010.090467. Epub 2010 Feb 11.

11.

AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells.

Lorenzato A, Biolatti M, Delogu G, Capobianco G, Farace C, Dessole S, Cossu A, Tanda F, Madeddu R, Olivero M, Di Renzo MF.

Exp Cell Res. 2013 Oct 15;319(17):2627-36. doi: 10.1016/j.yexcr.2013.07.030. Epub 2013 Aug 13.

PMID:
23948303
12.

High nuclear expression of phosphorylated extracellular signal-regulated kinase in tumor cells in colorectal glands is associated with poor outcome in colorectal cancer.

Tai CJ, Lee CH, Chen HC, Wang HK, Jiang MC, Su TC, Shen KH, Lin SH, Yeh CM, Chen CJ, Yeh KT, Chang CC.

Ann Diagn Pathol. 2013 Apr;17(2):165-71. doi: 10.1016/j.anndiagpath.2012.09.004. Epub 2012 Nov 24.

PMID:
23183114
13.

High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi.

Chin SY, Wu PR, Shih YH, Yeh CM, Lee WR, Shen SC, Yeh KT, Jiang MC, Tseng JT.

Int J Clin Exp Pathol. 2015 Feb 1;8(2):1393-401. eCollection 2015.

14.

The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.

Zheng HC, Xia P, Xu XY, Takahashi H, Takano Y.

Hum Pathol. 2011 Mar;42(3):424-33. doi: 10.1016/j.humpath.2009.12.018. Epub 2010 Dec 28.

PMID:
21193223
15.

Does CSE1L Overexpression Affect Distant Metastasis Development in Breast Cancer?

Yuksel UM, Turker I, Dilek G, Dogan L, Gulcelik MA, Oksuzoglu B.

Oncol Res Treat. 2015;38(9):431-4. doi: 10.1159/000438501. Epub 2015 Aug 10.

PMID:
26278417
16.

High level of Notch1 protein is associated with poor overall survival in colorectal cancer.

Chu D, Li Y, Wang W, Zhao Q, Li J, Lu Y, Li M, Dong G, Zhang H, Xie H, Ji G.

Ann Surg Oncol. 2010 May;17(5):1337-42. doi: 10.1245/s10434-009-0893-7. Epub 2010 Jan 8.

PMID:
20058190
17.

Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.

Bosari S, Viale G, Bossi P, Maggioni M, Coggi G, Murray JJ, Lee AK.

J Natl Cancer Inst. 1994 May 4;86(9):681-7.

PMID:
8158699
18.

RhoE is associated with relapse and prognosis of patients with colorectal cancer.

Zhou J, Yang J, Li K, Mo P, Feng B, Wang X, Nie Y, Fan D.

Ann Surg Oncol. 2013 Jan;20(1):175-82. doi: 10.1245/s10434-012-2472-6. Epub 2012 Sep 1.

PMID:
22941156
19.

Expression of cyclooxygenase-2 protein in colorectal carcinomas.

Joo YE, Kim HS, Min SW, Lee WS, Park CH, Park CS, Choi SK, Rew JS, Kim SJ.

Int J Gastrointest Cancer. 2002;31(1-3):147-54.

PMID:
12622426
20.

Presence of CSE1L protein in urine of patients with urinary bladder urothelial carcinomas.

Tai CJ, Liao CF, Su TC, Shen KH, Chang CC, Lin SH, Yeh CM, Shen SC, Lee WR, Chiou JF, Lin CH, Chen YC, Shih HY, Yeh KT, Jiang MC.

Int J Biol Markers. 2012 Oct 8;27(3):e280-4. doi: 10.5301/JBM.2012.9310.

PMID:
22653741

Supplemental Content

Support Center